Borgeson Blake sold RXRX
April 7, 2026 · Form 4 insider transaction
Borgeson Blake sold 30,000 shares of Recursion Pharmaceuticals, Inc. at $3.10 per share, a transaction worth $93.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
30,000
Price
$3.10
Total value
$93.0K
InsiderBorgeson Blake
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateApril 7, 2026
Filing dateApril 8, 2026
Shares owned after6,229,863
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.